Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Nature Communications|May 17, 2023
Cellular population dynamics shape the route to human pluripotencyFrancesco Panariello, Onelia Gagliano, Camilla Luni, et al.Nature Cell Biology|October 22, 2021
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myelomaJulia Frede, Praveen Anand, Noori Sotudeh, et al.Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in <i>BRAF</i>-Mutated Multiple MyelomaJohannes M Waldschmidt, Jake A Kloeber, Praveen Anand, et al.Nature Communications|November 17, 2021
SARS-CoV-2 infection and replication in human gastric organoidsGiovanni Giuseppe Giobbe, Francesco Bonfante, Brendan C Jones, et al.Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.Leukemia|September 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myelomaJulia Frede, Julia C Poller, Kayleen Shi, et al.Cancer Discovery|November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanomaEliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.Pageof 8